Abstract
Background and Aims: Bold Hypertriglyceridemia has emerged as an important coronary artery disease (CAD) risk factor. Rare loss of function (LOF) variants in apolipoprotein CIII have been reported to reduce triglycerides (TG) and decrease the risk of CAD in American Indians and Europeans. However, there is a paucity of data on whether these variants are cardioprotective in other European and non-European populations. Also, whether genetically increased TG due to ApoCIII is causally associated with increased CAD risk is still unclear and inconsistent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
